ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

GUILLERMO MENDOZA FONSECA M.D.

201 N PARK AVE SUITE 301

Apopka | Florida | 32703

(407) 889-1030

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,291Medicare Part D Prescriptions Filled, Including Refills

Rank: 1616 out of 3647

$293K Total Retail Price of All Prescriptions

Rank: 2028 out of 3647

219 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 219 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 219 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 4,348 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 268 184 1 3
METFORMIN HCL 262 152 2 6
AMLODIPINE BESYLATE 236 206 3 2
SIMVASTATIN 219 149 4 1
LOVASTATIN 216 152 5 21
LISINOPRIL 172 111 6 4
ALENDRONATE SODIUM 166 138 7 23
LEVOTHYROXINE SODIUM 142 121 8 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 87 9 36
LOSARTAN POTASSIUM 133 121 10 11
ATENOLOL 125 92 11 10
GABAPENTIN 121 57 12 17
GLIPIZIDE ER 120 73 13 112
ATENOLOL-CHLORTHALIDONE 120 98 13 171
TRAMADOL HCL 116 69 15 22
ATORVASTATIN CALCIUM 109 77 16 13
NAPROXEN 96 53 17 70
WARFARIN SODIUM 95 51 18 15
FUROSEMIDE 89 78 19 8
RANITIDINE HCL 88 55 20 29
TAMSULOSIN HCL 83 75 21 28
PROAIR HFA 76 51 22 62
ZOLPIDEM TARTRATE 74 40 23 14
SPIRIVA 72 53 24 93
ADVAIR DISKUS 65 24 25 52
LOSARTAN-HYDROCHLOROTHIAZIDE 64 51 26 48
METOPROLOL TARTRATE 64 49 26 7
PRAVASTATIN SODIUM 62 48 28 16
LANTUS 61 43 29 59
OXYCODONE HCL 61 29 S2 29 75
HYDROCHLOROTHIAZIDE 61 55 29 9
FLUOXETINE HCL 56 12 32 68
BACLOFEN 55 21 33 97
FLUTICASONE PROPIONATE 54 48 34 32
PANTOPRAZOLE SODIUM 51 30 35 38
DIOVAN HCT 51 44 35 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.